Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)

NCT01545388 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

337

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Metformin
DRUG: Metformin
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC